A randomized controlled study to assess the effect of mosapride citrate on intestinal recovery following gastrectomy
Authors:
Open Access
- 25 March 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-8
Abstract
The enhanced recovery after surgery (ERAS) protocol, including prokinetic medications, is commonly used to prevent postoperative ileus. Prospective studies evaluating the effectiveness of mosapride citrate, a prokinetic 5-hydroxytryptamine 4 receptor agonist, in patients undergoing gastrectomy within the ERAS framework are lacking. This double-blind randomized trial included patients who were scheduled for laparoscopic or robotic gastrectomy for gastric cancer. Participants were randomly assigned to either a control (placebo) or experimental (mosapride citrate) group, with drugs administered on postoperative days 1–5. Bowel motility was evaluated based on bowel transit time measured using radiopaque markers, first-flatus time, and amount of food intake. No significant differences were observed in baseline characteristics between the two groups. On postoperative day 3, no significant difference was observed in the number of radiopaque markers visible in the colon between the groups. All factors associated with bowel recovery, including the time of first flatus, length of hospital stay, amount of food intake, and severity of abdominal discomfort, were similar between the two groups. Mosapride citrate does not benefit the recovery of intestinal motility after minimally invasive gastrectomy in patients with gastric cancer. Therefore, routine postoperative use of mosapride citrate is not recommended in such patients.Keywords
Funding Information
- Yonsei University College of Medicine (2019-32-0021)
This publication has 30 references indexed in Scilit:
- Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)Gastric Cancer, 2022
- Enhanced Recovery After SurgeryJAMA Surgery, 2017
- Diabetes-Related Dysfunction of the Small Intestine and the Colon: Focus on MotilityCurrent Diabetes Reports, 2015
- Consensus guidelines for enhanced recovery after gastrectomyBritish Journal of Surgery, 2014
- Mosapride Citrate Improves Postoperative Ileus of Patients with ColectomyJournal of Gastrointestinal Surgery, 2011
- Usefulness of enhanced recovery after surgery protocol as compared with conventional perioperative care in gastric surgeryGastric Cancer, 2011
- The effect of mosapride citrate on constipation in patients with diabetesDiabetes Research and Clinical Practice, 2010
- Effect of Mosapride on Recovery of Intestinal Motility After Hand-Assisted Laparoscopic Colectomy for CarcinomaDiseases of the Colon & Rectum, 2008
- Review of the Pathophysiology and Management of Postoperative IleusWorld Journal of Surgery, 2006
- Mosapride citrate, a novel 5‐HT4 agonist and partial 5‐HT3 antagonist, ameliorates constipation in parkinsonian patientsMovement Disorders, 2005